The International Myeloma Working Group (IMWG), which comprises 85 investigators specializing in the area of multiple myeloma, has reviewed and considered the recent Mayo Clinic consensus statement for the use of bisphosphonates (BPs) in multiple myeloma. Although the IMWG is in general agreement with the Mayo consensus statement, several important issues have been raised and are discussed subsequently. These comments are in response to the recommendations of the Mayo group, which is normally part of the IMWG.
Mayo Clin Proc. 2007 Apr;82(4):516-7; author reply 517-8.